Moderna CFO’s Departure Reignites Debate Over Company’s Culture

Moderna became a $50bn success story by developing a Covid-19 vaccine at an unprecedented pace. But the biotech may have broken a less illustrious speed record this week when it removed its chief financial officer after just a day in the job. The Boston-based biotech said Jorge Gomez was leaving the company following the disclosure of an investigation at his former employer, the dental equipment maker Dentsply Sirona, which it said was linked to financial reporting issues...
Login to comment.